nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—MAOB—myometrium—uterine cancer	0.0107	0.0743	CbGeAlD
Linezolid—MAOA—myometrium—uterine cancer	0.00916	0.0634	CbGeAlD
Linezolid—MAOB—uterine cervix—uterine cancer	0.00835	0.0578	CbGeAlD
Linezolid—MAOB—decidua—uterine cancer	0.00796	0.0551	CbGeAlD
Linezolid—MAOB—renal system—uterine cancer	0.00781	0.0541	CbGeAlD
Linezolid—MAOB—endometrium—uterine cancer	0.00755	0.0523	CbGeAlD
Linezolid—MAOB—mammalian vulva—uterine cancer	0.00731	0.0506	CbGeAlD
Linezolid—MAOA—uterine cervix—uterine cancer	0.00713	0.0493	CbGeAlD
Linezolid—MAOB—uterus—uterine cancer	0.00696	0.0482	CbGeAlD
Linezolid—MAOA—decidua—uterine cancer	0.00679	0.047	CbGeAlD
Linezolid—MAOA—renal system—uterine cancer	0.00667	0.0461	CbGeAlD
Linezolid—MAOA—endometrium—uterine cancer	0.00644	0.0446	CbGeAlD
Linezolid—MAOB—female reproductive system—uterine cancer	0.00626	0.0433	CbGeAlD
Linezolid—MAOA—mammalian vulva—uterine cancer	0.00623	0.0432	CbGeAlD
Linezolid—MAOA—uterus—uterine cancer	0.00594	0.0411	CbGeAlD
Linezolid—MAOB—female gonad—uterine cancer	0.00569	0.0394	CbGeAlD
Linezolid—MAOB—vagina—uterine cancer	0.00566	0.0392	CbGeAlD
Linezolid—MAOA—female reproductive system—uterine cancer	0.00534	0.037	CbGeAlD
Linezolid—MAOA—female gonad—uterine cancer	0.00486	0.0336	CbGeAlD
Linezolid—MAOA—vagina—uterine cancer	0.00483	0.0334	CbGeAlD
Linezolid—MAOB—lymph node—uterine cancer	0.00366	0.0253	CbGeAlD
Linezolid—MAOA—lymph node—uterine cancer	0.00312	0.0216	CbGeAlD
Linezolid—Constipation—Progesterone—uterine cancer	0.0019	0.00222	CcSEcCtD
Linezolid—Pain—Progesterone—uterine cancer	0.0019	0.00222	CcSEcCtD
Linezolid—Pancytopenia—Etoposide—uterine cancer	0.00189	0.00221	CcSEcCtD
Linezolid—Jaundice cholestatic—Doxorubicin—uterine cancer	0.00188	0.00219	CcSEcCtD
Linezolid—Neutropenia—Etoposide—uterine cancer	0.00187	0.00218	CcSEcCtD
Linezolid—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00182	0.00212	CcSEcCtD
Linezolid—Gastrointestinal pain—Progesterone—uterine cancer	0.00181	0.00212	CcSEcCtD
Linezolid—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00211	CcSEcCtD
Linezolid—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00209	CcSEcCtD
Linezolid—Glossitis—Doxorubicin—uterine cancer	0.00179	0.00209	CcSEcCtD
Linezolid—Pneumonia—Etoposide—uterine cancer	0.00179	0.00209	CcSEcCtD
Linezolid—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00209	CcSEcCtD
Linezolid—Vaginal inflammation—Epirubicin—uterine cancer	0.00178	0.00208	CcSEcCtD
Linezolid—Anaemia—Dactinomycin—uterine cancer	0.00178	0.00208	CcSEcCtD
Linezolid—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00177	0.00207	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00176	0.00206	CcSEcCtD
Linezolid—Urticaria—Progesterone—uterine cancer	0.00176	0.00206	CcSEcCtD
Linezolid—Body temperature increased—Progesterone—uterine cancer	0.00175	0.00205	CcSEcCtD
Linezolid—Abdominal pain—Progesterone—uterine cancer	0.00175	0.00205	CcSEcCtD
Linezolid—Renal failure—Etoposide—uterine cancer	0.00175	0.00204	CcSEcCtD
Linezolid—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00175	0.00204	CcSEcCtD
Linezolid—Neuropathy peripheral—Etoposide—uterine cancer	0.00174	0.00204	CcSEcCtD
Linezolid—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00174	0.00203	CcSEcCtD
Linezolid—Stomatitis—Etoposide—uterine cancer	0.00173	0.00203	CcSEcCtD
Linezolid—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00203	CcSEcCtD
Linezolid—Leukopenia—Dactinomycin—uterine cancer	0.00172	0.00201	CcSEcCtD
Linezolid—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00172	0.00201	CcSEcCtD
Linezolid—Candida infection—Epirubicin—uterine cancer	0.0017	0.00199	CcSEcCtD
Linezolid—Fluid retention—Epirubicin—uterine cancer	0.00169	0.00198	CcSEcCtD
Linezolid—Vaginal infection—Epirubicin—uterine cancer	0.00168	0.00197	CcSEcCtD
Linezolid—Neuropathy—Epirubicin—uterine cancer	0.00167	0.00196	CcSEcCtD
Linezolid—Vaginal inflammation—Doxorubicin—uterine cancer	0.00165	0.00193	CcSEcCtD
Linezolid—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00192	CcSEcCtD
Linezolid—Ecchymosis—Epirubicin—uterine cancer	0.00161	0.00188	CcSEcCtD
Linezolid—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00187	CcSEcCtD
Linezolid—Asthenia—Progesterone—uterine cancer	0.00159	0.00186	CcSEcCtD
Linezolid—Hypoaesthesia—Etoposide—uterine cancer	0.00159	0.00186	CcSEcCtD
Linezolid—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00159	0.00186	CcSEcCtD
Linezolid—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00159	0.00186	CcSEcCtD
Linezolid—Candida infection—Doxorubicin—uterine cancer	0.00157	0.00184	CcSEcCtD
Linezolid—Pruritus—Progesterone—uterine cancer	0.00157	0.00183	CcSEcCtD
Linezolid—Fluid retention—Doxorubicin—uterine cancer	0.00157	0.00183	CcSEcCtD
Linezolid—Vaginal infection—Doxorubicin—uterine cancer	0.00156	0.00182	CcSEcCtD
Linezolid—Neuropathy—Doxorubicin—uterine cancer	0.00155	0.00181	CcSEcCtD
Linezolid—Sepsis—Epirubicin—uterine cancer	0.00155	0.00181	CcSEcCtD
Linezolid—Thrombocytopenia—Dactinomycin—uterine cancer	0.00153	0.00179	CcSEcCtD
Linezolid—Diarrhoea—Progesterone—uterine cancer	0.00152	0.00177	CcSEcCtD
Linezolid—Erythema multiforme—Etoposide—uterine cancer	0.00151	0.00176	CcSEcCtD
Linezolid—Phlebitis—Epirubicin—uterine cancer	0.0015	0.00176	CcSEcCtD
Linezolid—Thrombophlebitis—Epirubicin—uterine cancer	0.00149	0.00175	CcSEcCtD
Linezolid—Anorexia—Dactinomycin—uterine cancer	0.00149	0.00175	CcSEcCtD
Linezolid—Ecchymosis—Doxorubicin—uterine cancer	0.00149	0.00174	CcSEcCtD
Linezolid—Dizziness—Progesterone—uterine cancer	0.00147	0.00171	CcSEcCtD
Linezolid—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00169	CcSEcCtD
Linezolid—Chills—Etoposide—uterine cancer	0.00143	0.00167	CcSEcCtD
Linezolid—Sepsis—Doxorubicin—uterine cancer	0.00143	0.00167	CcSEcCtD
Linezolid—Cardiac failure congestive—Epirubicin—uterine cancer	0.00143	0.00167	CcSEcCtD
Linezolid—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00166	CcSEcCtD
Linezolid—Vomiting—Progesterone—uterine cancer	0.00141	0.00165	CcSEcCtD
Linezolid—Rash—Progesterone—uterine cancer	0.0014	0.00163	CcSEcCtD
Linezolid—Dermatitis—Progesterone—uterine cancer	0.0014	0.00163	CcSEcCtD
Linezolid—Phlebitis—Doxorubicin—uterine cancer	0.00139	0.00162	CcSEcCtD
Linezolid—Headache—Progesterone—uterine cancer	0.00139	0.00162	CcSEcCtD
Linezolid—Thrombophlebitis—Doxorubicin—uterine cancer	0.00138	0.00162	CcSEcCtD
Linezolid—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00161	CcSEcCtD
Linezolid—Decreased appetite—Dactinomycin—uterine cancer	0.00136	0.00159	CcSEcCtD
Linezolid—Dysgeusia—Etoposide—uterine cancer	0.00136	0.00159	CcSEcCtD
Linezolid—Fatigue—Dactinomycin—uterine cancer	0.00135	0.00158	CcSEcCtD
Linezolid—Pain—Dactinomycin—uterine cancer	0.00134	0.00157	CcSEcCtD
Linezolid—Muscle spasms—Etoposide—uterine cancer	0.00134	0.00156	CcSEcCtD
Linezolid—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00155	CcSEcCtD
Linezolid—Hypoglycaemia—Epirubicin—uterine cancer	0.00133	0.00155	CcSEcCtD
Linezolid—Cardiac failure congestive—Doxorubicin—uterine cancer	0.00132	0.00154	CcSEcCtD
Linezolid—Nausea—Progesterone—uterine cancer	0.00132	0.00154	CcSEcCtD
Linezolid—Hyponatraemia—Epirubicin—uterine cancer	0.0013	0.00152	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.00129	0.00151	CcSEcCtD
Linezolid—Anaemia—Etoposide—uterine cancer	0.00128	0.0015	CcSEcCtD
Linezolid—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00128	0.0015	CcSEcCtD
Linezolid—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00149	CcSEcCtD
Linezolid—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00148	CcSEcCtD
Linezolid—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00148	CcSEcCtD
Linezolid—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00147	CcSEcCtD
Linezolid—Vertigo—Etoposide—uterine cancer	0.00125	0.00146	CcSEcCtD
Linezolid—Leukopenia—Etoposide—uterine cancer	0.00124	0.00145	CcSEcCtD
Linezolid—Abdominal pain—Dactinomycin—uterine cancer	0.00124	0.00145	CcSEcCtD
Linezolid—Body temperature increased—Dactinomycin—uterine cancer	0.00124	0.00145	CcSEcCtD
Linezolid—Hypoglycaemia—Doxorubicin—uterine cancer	0.00123	0.00143	CcSEcCtD
Linezolid—Cough—Etoposide—uterine cancer	0.00121	0.00142	CcSEcCtD
Linezolid—Convulsion—Etoposide—uterine cancer	0.0012	0.00141	CcSEcCtD
Linezolid—Hyponatraemia—Doxorubicin—uterine cancer	0.0012	0.00141	CcSEcCtD
Linezolid—Hypertension—Etoposide—uterine cancer	0.0012	0.0014	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.0012	0.0014	CcSEcCtD
Linezolid—Liver function test abnormal—Epirubicin—uterine cancer	0.00119	0.0014	CcSEcCtD
Linezolid—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.0014	CcSEcCtD
Linezolid—Hypokalaemia—Epirubicin—uterine cancer	0.00118	0.00138	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00117	0.00136	CcSEcCtD
Linezolid—Gastritis—Epirubicin—uterine cancer	0.00115	0.00134	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.00114	0.00133	CcSEcCtD
Linezolid—Anaphylactic shock—Etoposide—uterine cancer	0.00113	0.00133	CcSEcCtD
Linezolid—Asthenia—Dactinomycin—uterine cancer	0.00112	0.00131	CcSEcCtD
Linezolid—Thrombocytopenia—Etoposide—uterine cancer	0.00111	0.0013	CcSEcCtD
Linezolid—Eosinophilia—Epirubicin—uterine cancer	0.00111	0.00129	CcSEcCtD
Linezolid—Liver function test abnormal—Doxorubicin—uterine cancer	0.00111	0.00129	CcSEcCtD
Linezolid—Skin disorder—Etoposide—uterine cancer	0.0011	0.00129	CcSEcCtD
Linezolid—Hyperhidrosis—Etoposide—uterine cancer	0.0011	0.00128	CcSEcCtD
Linezolid—Pancreatitis—Epirubicin—uterine cancer	0.0011	0.00128	CcSEcCtD
Linezolid—Hypokalaemia—Doxorubicin—uterine cancer	0.00109	0.00127	CcSEcCtD
Linezolid—Anorexia—Etoposide—uterine cancer	0.00108	0.00126	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00108	0.00126	CcSEcCtD
Linezolid—Diarrhoea—Dactinomycin—uterine cancer	0.00107	0.00125	CcSEcCtD
Linezolid—Pancytopenia—Epirubicin—uterine cancer	0.00106	0.00124	CcSEcCtD
Linezolid—Gastritis—Doxorubicin—uterine cancer	0.00106	0.00124	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00106	0.00123	CcSEcCtD
Linezolid—Neutropenia—Epirubicin—uterine cancer	0.00105	0.00122	CcSEcCtD
Linezolid—Upper respiratory tract infection—Epirubicin—uterine cancer	0.00104	0.00121	CcSEcCtD
Linezolid—Eosinophilia—Doxorubicin—uterine cancer	0.00102	0.0012	CcSEcCtD
Linezolid—Paraesthesia—Etoposide—uterine cancer	0.00102	0.00119	CcSEcCtD
Linezolid—Pancreatitis—Doxorubicin—uterine cancer	0.00101	0.00119	CcSEcCtD
Linezolid—Dyspnoea—Etoposide—uterine cancer	0.00101	0.00118	CcSEcCtD
Linezolid—Hyperglycaemia—Epirubicin—uterine cancer	0.00101	0.00118	CcSEcCtD
Linezolid—Somnolence—Etoposide—uterine cancer	0.00101	0.00118	CcSEcCtD
Linezolid—Pneumonia—Epirubicin—uterine cancer	0.001	0.00117	CcSEcCtD
Linezolid—Vomiting—Dactinomycin—uterine cancer	0.000997	0.00117	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000989	0.00116	CcSEcCtD
Linezolid—Rash—Dactinomycin—uterine cancer	0.000988	0.00116	CcSEcCtD
Linezolid—Decreased appetite—Etoposide—uterine cancer	0.000986	0.00115	CcSEcCtD
Linezolid—Pancytopenia—Doxorubicin—uterine cancer	0.000983	0.00115	CcSEcCtD
Linezolid—Renal failure—Epirubicin—uterine cancer	0.00098	0.00115	CcSEcCtD
Linezolid—Gastrointestinal disorder—Etoposide—uterine cancer	0.00098	0.00114	CcSEcCtD
Linezolid—Fatigue—Etoposide—uterine cancer	0.000978	0.00114	CcSEcCtD
Linezolid—Neuropathy peripheral—Epirubicin—uterine cancer	0.000977	0.00114	CcSEcCtD
Linezolid—Stomatitis—Epirubicin—uterine cancer	0.000972	0.00114	CcSEcCtD
Linezolid—Pain—Etoposide—uterine cancer	0.00097	0.00113	CcSEcCtD
Linezolid—Constipation—Etoposide—uterine cancer	0.00097	0.00113	CcSEcCtD
Linezolid—Neutropenia—Doxorubicin—uterine cancer	0.000968	0.00113	CcSEcCtD
Linezolid—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000962	0.00112	CcSEcCtD
Linezolid—Hyperglycaemia—Doxorubicin—uterine cancer	0.000933	0.00109	CcSEcCtD
Linezolid—Nausea—Dactinomycin—uterine cancer	0.000931	0.00109	CcSEcCtD
Linezolid—Pneumonia—Doxorubicin—uterine cancer	0.000928	0.00108	CcSEcCtD
Linezolid—Gastrointestinal pain—Etoposide—uterine cancer	0.000928	0.00108	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000915	0.00107	CcSEcCtD
Linezolid—Renal failure—Doxorubicin—uterine cancer	0.000907	0.00106	CcSEcCtD
Linezolid—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000904	0.00106	CcSEcCtD
Linezolid—Urticaria—Etoposide—uterine cancer	0.000901	0.00105	CcSEcCtD
Linezolid—Haemoglobin—Epirubicin—uterine cancer	0.0009	0.00105	CcSEcCtD
Linezolid—Stomatitis—Doxorubicin—uterine cancer	0.000899	0.00105	CcSEcCtD
Linezolid—Body temperature increased—Etoposide—uterine cancer	0.000897	0.00105	CcSEcCtD
Linezolid—Abdominal pain—Etoposide—uterine cancer	0.000897	0.00105	CcSEcCtD
Linezolid—Haemorrhage—Epirubicin—uterine cancer	0.000895	0.00105	CcSEcCtD
Linezolid—Hypoaesthesia—Epirubicin—uterine cancer	0.000891	0.00104	CcSEcCtD
Linezolid—Pharyngitis—Epirubicin—uterine cancer	0.000888	0.00104	CcSEcCtD
Linezolid—Erythema multiforme—Epirubicin—uterine cancer	0.000846	0.000989	CcSEcCtD
Linezolid—Tinnitus—Epirubicin—uterine cancer	0.000835	0.000976	CcSEcCtD
Linezolid—Haemoglobin—Doxorubicin—uterine cancer	0.000832	0.000973	CcSEcCtD
Linezolid—Haemorrhage—Doxorubicin—uterine cancer	0.000828	0.000968	CcSEcCtD
Linezolid—Hypoaesthesia—Doxorubicin—uterine cancer	0.000824	0.000963	CcSEcCtD
Linezolid—Pharyngitis—Doxorubicin—uterine cancer	0.000822	0.000961	CcSEcCtD
Linezolid—Asthenia—Etoposide—uterine cancer	0.000814	0.000951	CcSEcCtD
Linezolid—Chills—Epirubicin—uterine cancer	0.000803	0.000939	CcSEcCtD
Linezolid—Pruritus—Etoposide—uterine cancer	0.000803	0.000938	CcSEcCtD
Linezolid—Erythema multiforme—Doxorubicin—uterine cancer	0.000783	0.000915	CcSEcCtD
Linezolid—Erythema—Epirubicin—uterine cancer	0.000779	0.000911	CcSEcCtD
Linezolid—Diarrhoea—Etoposide—uterine cancer	0.000776	0.000907	CcSEcCtD
Linezolid—Tinnitus—Doxorubicin—uterine cancer	0.000772	0.000903	CcSEcCtD
Linezolid—Flatulence—Epirubicin—uterine cancer	0.000768	0.000898	CcSEcCtD
Linezolid—Dysgeusia—Epirubicin—uterine cancer	0.000763	0.000892	CcSEcCtD
Linezolid—Dizziness—Etoposide—uterine cancer	0.00075	0.000877	CcSEcCtD
Linezolid—Muscle spasms—Epirubicin—uterine cancer	0.000749	0.000876	CcSEcCtD
Linezolid—Chills—Doxorubicin—uterine cancer	0.000743	0.000869	CcSEcCtD
Linezolid—Vision blurred—Epirubicin—uterine cancer	0.000734	0.000858	CcSEcCtD
Linezolid—Vomiting—Etoposide—uterine cancer	0.000721	0.000843	CcSEcCtD
Linezolid—Erythema—Doxorubicin—uterine cancer	0.000721	0.000843	CcSEcCtD
Linezolid—Anaemia—Epirubicin—uterine cancer	0.00072	0.000842	CcSEcCtD
Linezolid—Rash—Etoposide—uterine cancer	0.000715	0.000836	CcSEcCtD
Linezolid—Dermatitis—Etoposide—uterine cancer	0.000715	0.000835	CcSEcCtD
Linezolid—Headache—Etoposide—uterine cancer	0.000711	0.000831	CcSEcCtD
Linezolid—Flatulence—Doxorubicin—uterine cancer	0.000711	0.00083	CcSEcCtD
Linezolid—Dysgeusia—Doxorubicin—uterine cancer	0.000706	0.000825	CcSEcCtD
Linezolid—Vertigo—Epirubicin—uterine cancer	0.0007	0.000818	CcSEcCtD
Linezolid—Leukopenia—Epirubicin—uterine cancer	0.000698	0.000815	CcSEcCtD
Linezolid—Muscle spasms—Doxorubicin—uterine cancer	0.000693	0.00081	CcSEcCtD
Linezolid—Cough—Epirubicin—uterine cancer	0.00068	0.000795	CcSEcCtD
Linezolid—Vision blurred—Doxorubicin—uterine cancer	0.00068	0.000794	CcSEcCtD
Linezolid—Convulsion—Epirubicin—uterine cancer	0.000675	0.000789	CcSEcCtD
Linezolid—Nausea—Etoposide—uterine cancer	0.000674	0.000788	CcSEcCtD
Linezolid—Hypertension—Epirubicin—uterine cancer	0.000673	0.000786	CcSEcCtD
Linezolid—Anaemia—Doxorubicin—uterine cancer	0.000666	0.000779	CcSEcCtD
Linezolid—Dry mouth—Epirubicin—uterine cancer	0.000649	0.000758	CcSEcCtD
Linezolid—Vertigo—Doxorubicin—uterine cancer	0.000648	0.000757	CcSEcCtD
Linezolid—Leukopenia—Doxorubicin—uterine cancer	0.000645	0.000754	CcSEcCtD
Linezolid—Anaphylactic shock—Epirubicin—uterine cancer	0.000636	0.000743	CcSEcCtD
Linezolid—Cough—Doxorubicin—uterine cancer	0.000629	0.000735	CcSEcCtD
Linezolid—Convulsion—Doxorubicin—uterine cancer	0.000625	0.00073	CcSEcCtD
Linezolid—Thrombocytopenia—Epirubicin—uterine cancer	0.000623	0.000728	CcSEcCtD
Linezolid—Hypertension—Doxorubicin—uterine cancer	0.000623	0.000728	CcSEcCtD
Linezolid—Skin disorder—Epirubicin—uterine cancer	0.000618	0.000722	CcSEcCtD
Linezolid—Hyperhidrosis—Epirubicin—uterine cancer	0.000615	0.000719	CcSEcCtD
Linezolid—Anorexia—Epirubicin—uterine cancer	0.000606	0.000709	CcSEcCtD
Linezolid—Dry mouth—Doxorubicin—uterine cancer	0.0006	0.000702	CcSEcCtD
Linezolid—Anaphylactic shock—Doxorubicin—uterine cancer	0.000588	0.000688	CcSEcCtD
Linezolid—Thrombocytopenia—Doxorubicin—uterine cancer	0.000576	0.000673	CcSEcCtD
Linezolid—Insomnia—Epirubicin—uterine cancer	0.000575	0.000672	CcSEcCtD
Linezolid—Skin disorder—Doxorubicin—uterine cancer	0.000572	0.000668	CcSEcCtD
Linezolid—Paraesthesia—Epirubicin—uterine cancer	0.000571	0.000668	CcSEcCtD
Linezolid—Hyperhidrosis—Doxorubicin—uterine cancer	0.000569	0.000665	CcSEcCtD
Linezolid—Dyspnoea—Epirubicin—uterine cancer	0.000567	0.000663	CcSEcCtD
Linezolid—Somnolence—Epirubicin—uterine cancer	0.000565	0.000661	CcSEcCtD
Linezolid—Anorexia—Doxorubicin—uterine cancer	0.000561	0.000656	CcSEcCtD
Linezolid—Dyspepsia—Epirubicin—uterine cancer	0.00056	0.000654	CcSEcCtD
Linezolid—Decreased appetite—Epirubicin—uterine cancer	0.000553	0.000646	CcSEcCtD
Linezolid—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000549	0.000642	CcSEcCtD
Linezolid—Fatigue—Epirubicin—uterine cancer	0.000548	0.000641	CcSEcCtD
Linezolid—Pain—Epirubicin—uterine cancer	0.000544	0.000636	CcSEcCtD
Linezolid—Constipation—Epirubicin—uterine cancer	0.000544	0.000636	CcSEcCtD
Linezolid—Insomnia—Doxorubicin—uterine cancer	0.000532	0.000622	CcSEcCtD
Linezolid—Paraesthesia—Doxorubicin—uterine cancer	0.000528	0.000618	CcSEcCtD
Linezolid—Dyspnoea—Doxorubicin—uterine cancer	0.000525	0.000613	CcSEcCtD
Linezolid—Somnolence—Doxorubicin—uterine cancer	0.000523	0.000611	CcSEcCtD
Linezolid—Gastrointestinal pain—Epirubicin—uterine cancer	0.00052	0.000608	CcSEcCtD
Linezolid—Dyspepsia—Doxorubicin—uterine cancer	0.000518	0.000605	CcSEcCtD
Linezolid—Decreased appetite—Doxorubicin—uterine cancer	0.000512	0.000598	CcSEcCtD
Linezolid—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000508	0.000594	CcSEcCtD
Linezolid—Fatigue—Doxorubicin—uterine cancer	0.000507	0.000593	CcSEcCtD
Linezolid—Urticaria—Epirubicin—uterine cancer	0.000505	0.000591	CcSEcCtD
Linezolid—Constipation—Doxorubicin—uterine cancer	0.000503	0.000588	CcSEcCtD
Linezolid—Pain—Doxorubicin—uterine cancer	0.000503	0.000588	CcSEcCtD
Linezolid—Body temperature increased—Epirubicin—uterine cancer	0.000503	0.000588	CcSEcCtD
Linezolid—Abdominal pain—Epirubicin—uterine cancer	0.000503	0.000588	CcSEcCtD
Linezolid—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000481	0.000562	CcSEcCtD
Linezolid—Urticaria—Doxorubicin—uterine cancer	0.000467	0.000546	CcSEcCtD
Linezolid—Abdominal pain—Doxorubicin—uterine cancer	0.000465	0.000544	CcSEcCtD
Linezolid—Body temperature increased—Doxorubicin—uterine cancer	0.000465	0.000544	CcSEcCtD
Linezolid—Asthenia—Epirubicin—uterine cancer	0.000456	0.000533	CcSEcCtD
Linezolid—Pruritus—Epirubicin—uterine cancer	0.00045	0.000526	CcSEcCtD
Linezolid—Diarrhoea—Epirubicin—uterine cancer	0.000435	0.000509	CcSEcCtD
Linezolid—Asthenia—Doxorubicin—uterine cancer	0.000422	0.000493	CcSEcCtD
Linezolid—Dizziness—Epirubicin—uterine cancer	0.000421	0.000492	CcSEcCtD
Linezolid—Pruritus—Doxorubicin—uterine cancer	0.000416	0.000487	CcSEcCtD
Linezolid—Vomiting—Epirubicin—uterine cancer	0.000404	0.000473	CcSEcCtD
Linezolid—Diarrhoea—Doxorubicin—uterine cancer	0.000403	0.000471	CcSEcCtD
Linezolid—Rash—Epirubicin—uterine cancer	0.000401	0.000469	CcSEcCtD
Linezolid—Dermatitis—Epirubicin—uterine cancer	0.000401	0.000468	CcSEcCtD
Linezolid—Headache—Epirubicin—uterine cancer	0.000398	0.000466	CcSEcCtD
Linezolid—Dizziness—Doxorubicin—uterine cancer	0.000389	0.000455	CcSEcCtD
Linezolid—Nausea—Epirubicin—uterine cancer	0.000378	0.000442	CcSEcCtD
Linezolid—Vomiting—Doxorubicin—uterine cancer	0.000374	0.000437	CcSEcCtD
Linezolid—Rash—Doxorubicin—uterine cancer	0.000371	0.000434	CcSEcCtD
Linezolid—Dermatitis—Doxorubicin—uterine cancer	0.000371	0.000433	CcSEcCtD
Linezolid—Headache—Doxorubicin—uterine cancer	0.000369	0.000431	CcSEcCtD
Linezolid—Nausea—Doxorubicin—uterine cancer	0.00035	0.000409	CcSEcCtD
